# Alternative Options to Minimize Niacin-Induced Flushing

> **NCT00895193** · NA · COMPLETED · sponsor: **Patrick Moriarty, MD, FACP, FACC** · enrollment: 100 (actual)

## Conditions studied

- Hypercholesterolemia
- Flushing

## Interventions

- **OTHER:** Apple pectin
- **DRUG:** Aspirin 325 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00895193
- **Lead sponsor:** Patrick Moriarty, MD, FACP, FACC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895193, "Alternative Options to Minimize Niacin-Induced Flushing". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00895193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*